ON
← Back to feed
HT Morning News Brief Sept 19: India faces 100% tariff threat under US Act, Meghna Gulzar's film opens to slow response
India🏛️ PoliticsCenter5 hr. ago

HT Morning News Brief Sept 19: India faces 100% tariff threat under US Act, Meghna Gulzar's film opens to slow response

The article presents several news briefings covering different topics. It begins with international trade concerns, noting that India may face up to 100% tariffs on its exports to the U.S. due to the U.S. Congress passing the Lindsey O. Graham Sanctioning Russia and Iran Act. This act allows the president to impose tariffs on countries importing significant amounts of Russian oil and gas, including India. Next, it discusses internal corporate governance issues within Tata Sons, where the board's decision to extend N Chandrasekaran's tenure as chairman is questioned based on shareholder ownership percentages. The article also mentions the upcoming availability of India's first dengue vaccine, Qdenga, developed by Takeda Pharmaceuticals and distributed by Dr Reddy’s Laboratories, expected by mid-2027. Additionally, it reports on the modest box office performance of Meghna Gulzar's film 'Daayra,' starring Kareena Kapoor and Prithviraj Sukumaran, which earned approximately ₹90 lakh on its opening day. Lastly, it covers Neeraj Chopra's admission of missing the Asian Games due to injury, expressing personal disappointment.

Advertisement

1 reports

Hindustan Times logoHindustan TimesIndependentCenter5 hr. ago
HT Morning News Brief Sept 19: India faces 100% tariff threat under US Act, Meghna Gulzar's film opens to slow response

The article presents several news briefings covering different topics. It begins with international trade concerns, noting that India may face up to 100% tariffs on its exports to the U.S. due to the U.S. Congress passing the Lindsey O. Graham Sanctioning Russia and Iran Act. This act allows the president to impose tariffs on countries importing significant amounts of Russian oil and gas, including India. Next, it discusses internal corporate governance issues within Tata Sons, where the board's decision to extend N Chandrasekaran's tenure as chairman is questioned based on shareholder ownership percentages. The article also mentions the upcoming availability of India's first dengue vaccine, Qdenga, developed by Takeda Pharmaceuticals and distributed by Dr Reddy’s Laboratories, expected by mid-2027. Additionally, it reports on the modest box office performance of Meghna Gulzar's film 'Daayra,' starring Kareena Kapoor and Prithviraj Sukumaran, which earned approximately ₹90 lakh on its opening day. Lastly, it covers Neeraj Chopra's admission of missing the Asian Games due to injury, expressing personal disappointment.

Bias read (Center): The article provides balanced coverage of multiple topics without overtly favoring any particular political stance. While it reports on potential economic impacts related to U.S.-India trade relations, it does not take a clear ideological position. The corporate governance section focuses on factual

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.

Become a Supporter

Related stories